
USD
$0.00
(0.00%
)At Close (As of Dec 11, 2025)
$127.77B
Market Cap
27.0
P/E Ratio
3.69
EPS
$106.33
52 Week High
$76.99
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Total Assets | $92B |
| Total Current Assets | $24B |
| Cash And Cash Equivalents At Carrying Value | $2.2B |
| Cash And Short Term Investments | $2.2B |
| Inventory | $5.5B |
| Current Net Receivables | $6.5B |
| Total Non Current Assets | $68B |
| Property Plant Equipment | $7.9B |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $12B |
| Intangible Assets Excluding Goodwill | $12B |
| Goodwill | $42B |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $6.7B |
| Other Current Assets | $2.9B |
| Other Non Current Assets | - |
| Total Liabilities | $43B |
| Total Current Liabilities | $13B |
| Current Accounts Payable | $2.4B |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $2.9B |
| Total Non Current Liabilities | $31B |
| Capital Lease Obligations | $58M |
| Long Term Debt | $26B |
| Current Long Term Debt | $2.9B |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $29B |
| Other Current Liabilities | $7.6B |
| Other Non Current Liabilities | $1.8B |
| Total Shareholder Equity | $48B |
| Treasury Stock | - |
| Retained Earnings | $31B |
| Common Stock | $128K |
| Common Stock Shares Outstanding | $1.3B |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Medtronic plc is a leading global medical technology company headquartered in Fridley, Minnesota, specializing in the development and commercialization of advanced medical devices and therapies across key sectors such as cardiovascular, diabetes management, and neuromodulation. With a strong emphasis on innovation, Medtronic invests significantly in research and development to create cutting-edge healthcare solutions that enhance patient outcomes and quality of life. The company's commitment to sustainability and value-driven healthcare further strengthens its position as a pivotal player in the evolving medical device industry, ensuring it remains well-equipped to address the complex challenges of modern healthcare.